Advertisement

Topics

News and press releases: EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of liver damage

07:00 EST 10 Nov 2017 | European Medicines Agency

Zinbryta to be used in restricted patient group, with strict liver monitoring

Original Article: News and press releases: EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of liver damage

NEXT ARTICLE

More From BioPortfolio on "News and press releases: EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of liver damage"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...